Reduction in circulating vitamin D binding protein in patients with multiple sclerosis
Maghbooli, Zhila, Omidifar, Abolfazl, Varzandi, Tarlan, Salehnezhad, Tayebeh, Sahraian, Mohammad Ali
Published in BMC neurology (20.04.2021)
Published in BMC neurology (20.04.2021)
Get full text
Journal Article
The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder
Maghbooli, Zhila, Naser Moghadasi, Abdorreza, Rezaeimanesh, Nasim, Omidifar, Abolfazl, Varzandi, Tarlan, Sahraian, Mohammad Ali
Published in BMC neurology (20.04.2021)
Published in BMC neurology (20.04.2021)
Get full text
Journal Article
Effect of long-term nitrite administration on browning of white adipose tissue in type 2 diabetic rats: A stereological study
Varzandi, Tarlan, Abdollahifar, Mahammad Amin, Haeri Rohani, Seyed Ali, Piryaei, Abbas, Zadeh-Vakili, Azita, Jeddi, Sajad, Ghasemi, Asghar
Published in Life sciences (1973) (15.08.2018)
Published in Life sciences (1973) (15.08.2018)
Get full text
Journal Article
Understanding the Place of Environmental Factors in Familial Aggregation of Multiple Sclerosis
Maghbooli, Zhila, Razavi, Marzieh, Varzandi, Tarlan, Moghadasi, Abdorreza Naser, Poursadeghfard, Maryam, Karbasian, Amir Hossein
Published in Multiple sclerosis and related disorders (01.12.2023)
Published in Multiple sclerosis and related disorders (01.12.2023)
Get full text
Journal Article
Investigating the effects of 25-hydroxyvitamin D3 on clinical outcomes in multiple sclerosis patients: A randomized, double-blind clinical trial- a pilot study
Maghbooli, Zhila, Shirvani, Arash, Moghadasi, Abdorreza Naser, Varzandi, Tarlan, Hamtaei Ghashti, Sara, Sahraian, Mohammad Ali
Published in Multiple sclerosis and related disorders (01.07.2024)
Published in Multiple sclerosis and related disorders (01.07.2024)
Get full text
Journal Article
Treatment With 25-Hydroxyvitamin D 3 (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial
Maghbooli, Zhila, Sahraian, Mohammad Ali, Jamalimoghadamsiahkali, Saeidreza, Asadi, Asma, Zarei, Azadeh, Zendehdel, Abolfazl, Varzandi, Tarlan, Mohammadnabi, Sara, Alijani, Neda, Karimi, Mehrdad, Shirvani, Arash, Holick, Michael F
Published in Endocrine practice (01.12.2021)
Get more information
Published in Endocrine practice (01.12.2021)
Journal Article
Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infection
Maghbooli, Zhila, Hosseinpour, Hesham, Fattahi, Mohammad Reza, Varzandi, Tarlan, Hamtaeigashi, Sara, Mohammad-nabi, Sara, Aghababaei, Yasaman, Sahraian, Mohammad Ali
Published in Multiple sclerosis and related disorders (01.11.2022)
Published in Multiple sclerosis and related disorders (01.11.2022)
Get full text
Journal Article
Role of Type 1 Interferons therapy on Adverse Clinical Outcomes on COVID-19 in Hospitalized Multiple Sclerosis Patients
Maghbooli, Zhila, Sahraian, Mohammad Ali, Fattahi, Mohammad Reza, Varzandi, Tarlan, Hamtaeigashi, Sara, Mohammad-Nabi, Sara, Aghababaei, Yasaman
Published in Multiple sclerosis and related disorders (01.03.2023)
Published in Multiple sclerosis and related disorders (01.03.2023)
Get full text
Journal Article
Challenges of Antiviral Therapy on Clinical Outcomes and 30-Day Survival Benefits in Hospitalized Multiple Sclerosis Patients with COVID-19
Maghbooli, Zhila, Kasaeian, Amir, Reza Fattahi, Mohammad, Varzandi, Tarlan, Hamtaeigashi, Sara, Mohammadnabi, Sara, Ali Sahraian, Mohammad
Published in Acta Scientific Neurology (01.03.2024)
Published in Acta Scientific Neurology (01.03.2024)
Get full text
Journal Article